Citius Oncology
Cranford, New Jersey, United States · Biopharma, Biotechnology, Health Care
Citius Oncology, Inc. is a Delaware-based clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer. The company specializes in the development of novel cancer treatments, including targeted therapies and immunotherapies, designed to improve the effectiveness and safety of cancer care. Citius Oncology operates primarily in the United States and
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Cranford, New Jersey, United States
- Employees
- 19
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Public (CTOR)
- Company page
Recent activity at Citius Oncology
- : SEC 8-K (8.01):
- : SEC 8-K (5.07): On September 29, 2026, Citius Oncology, Inc. held its 2026 annual meeting of stockholders, during which stockholders elected Dr. Eugene Holuka, Robert Smith, and Carol Webb as Class II directors for a three-year term expiring in 2029. The voting results showed significant support for the nominees with over 67 million votes each for, alongside a few million withheld. Additionally, the stockholders ratified the selection of Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with over 73 million shares voting in favor. This meeting and its outcomes are critical as they affect the governance and future direction of the company.
- : SEC 8-K (5.02):
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About Citius Oncology: questions and answers
What does Citius Oncology do?
Citius Oncology, Inc. is a Delaware-based clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer. The company specializes in the development of novel cancer treatments, including targeted therapies and immunotherapies, designed to improve the effectiveness and safety of cancer care. Citius Oncology operates primarily in the United States and
Where is Citius Oncology headquartered?
Citius Oncology is headquartered in Cranford, New Jersey, United States.
How many employees does Citius Oncology have?
Citius Oncology has about 19 employees.
What is the latest news on Citius Oncology?
On Aug 12, 2026, SEC 8-K (8.01):
Is Citius Oncology a public company?
Yes. Citius Oncology is publicly traded under the ticker CTOR.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy